Tag Archives: Sciences

India axes exports of Gilead Sciences’ remdesivir, plots boost to local production as COVID cases mount: reports

India is one of the world’s biggest manufacturers of drugs and vaccines, but that hasn’t made it immune to COVID-19 supply instability. Now, the government is locking up at least one treatment for itself. As COVID-19 cases mount—and demand for treatments spikes—India has banned exports of Gilead Sciences’ pandemic antiviral remdesivir, Bloomberg reports, citing a statement… Read More »

Biomedical sciences researchers find new way to prevent and cure rotavirus, other viral infections

A combination of two substances secreted by the immune system can cure and prevent rotavirus infection, as well as potentially treat other viral infections that target epithelial cells, which cover body surfaces such as skin, blood vessels, organs and the urinary tract, according to researchers in the Institute for Biomedical Sciences at Georgia State University.… Read More »

Veradigm, Komodo Health work on new data set for life sciences

Veradigm, a payer and life sciences unit within Allscripts, has partnered with Komodo Health to create the largest linked electronic medical records and claims data set for life science research. The program combines Veradigm’s EHR data from Allscripts with a healthcare map from Komodo that offers almost 50 million linked and longitudinal patient records. The… Read More »

ATAI Life Sciences acquires majority stake in Perception Neuroscience to develop arketamine therapy for neuropsychiatric diseases

Munich and New York, 03 January 2019 – ATAI Life Sciences AG has acquired a majority stake in New York based Perception Neuroscience, a biopharmaceutical company focused on developing innovative therapies in neuropsychiatry. Perception was founded by Jonathan Sporn, MD, and Jay Kranzler, MD, PhD, both of whom have held multiple senior R&D leadership roles… Read More »